ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Correction: Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: a Phase I Dose Escalation and Expansion Study.

Andrea Wang-Gillam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.